Skip to main content

Advertisement

Table 2 Mean RSV-attributable burden of respiratory disease among the total population in the United Kingdom

From: Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom

Respiratory Outcome* Episodes /100,000 population (range) N % of events attributable to RSV** RSV:influenza ratio †
GP episodes
Respiratory disease 1579 (1055–1961) 927325 5.7 1.1:1
Acute upper respiratory disease 737 (509–884) 432716 6.0 1.2:1
Pneumonia and influenza 75 (34–123) 43825 8.5 0.2:1
Bronchitis/bronchiolitis 677 (472–801) 397665 11.5 1.6:1
COPD 70 (41–98) 41214 2.4 4.1:1
Antibiotic prescriptions 1553 (1111–1820) 912036 5.4 1.5:1
Hospitalisation (Primary diagnosis)
Respiratory disease 83 (61–101) 48600 9.0 1.7:1
Pneumonia and influenza 15 (11–19) 8599 9.3 1.2:1
COPD 10 (8–13) 5912 3.9 0.8:1
Cardiorespiratory 69 (49–81) 40255 4.5 1.6:1
Bronchitis/bronchiolitis 47 (34–57) 27806 28.4 3.4:1
Mortality (Any mention)
Respiratory disease 15 (11–21) 9034 5.8 0.8:1
Pneumonia and influenza 11 (8–15) 6603 7.0 0.7:1
COPD 4 (3–5) 2561 6.9 0.9:1
Cardiorespiratory 20 (16–26) 11600 3.9 0.8:1
Bronchitis/bronchiolitis 1 (0–1) 354 11.6 0.9:1
  1. N = Average seasonal number of specified RSV-attributable events for each outcome
  2. GP = general practice, COPD = chronic obstructive pulmonary disease
  3. Range = range of estimates per season
  4. *Outcomes refer to the ‘Primary’ cause for hospitalisation for HES, or as the ‘Any mention’ cause of death for ONS. For the GPRD data there is no ordered listing or ranking of diagnostic codes
  5. **% of RSV-attributable events among all events due to outcome, † ratio of proportions/100,000 RSV/[influenza A + B]